KPA to retort KMA's misleading advertising.

Published: 2002-11-08 06:56:00

Updated: 2002-11-08 06:56:00

The Korea Pharmaceutical Association (KPA) pointed out that the Korea Medical Association (KMA) took deceptive tricks to hurt the pharmacist community through their recent misleading public advertising largely in an attempt to hide irregularities in their practices, and therefore strongly urged t...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK